BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22075368)

  • 1. Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.
    Sugito K; Furuya T; Kaneda H; Masuko T; Ohashi K; Inoue M; Ikeda T; Koshinaga T; Yagasaki H; Mugishima H; Maebayashi T
    J Pediatr Surg; 2011 Nov; 46(11):e25-8. PubMed ID: 22075368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis carinii pneumonia: a late presentation following treatment for stage IV neuroblastoma.
    Clarke E; Glaser AW; Picton SV
    Pediatr Hematol Oncol; 2003 Sep; 20(6):467-71. PubMed ID: 14631621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Al-Faris N; Al Harbi T; Goia C; Pappo A; Doyle J; Gassas A
    Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
    Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single center experience with bone marrow transplantation for high risk neuroblastoma.
    Ladenstein R; Lasset C; Bouffet E; Brunat-Mentigny M; Biron P; Philip I; Chauvin F; Philip T
    Bone Marrow Transplant; 1991; 7 Suppl 2():93. PubMed ID: 1878741
    [No Abstract]   [Full Text] [Related]  

  • 7. Single or double consolidation treatment according to remission status after initial therapy in metastatic neuroblastoma: first results of LMCE 3 study in 40 patients.
    Zucker JM; Philip T; Bernard JL; Michon J; Bouffet E; Gentet JC; Lopez M; Coze C; Philip I
    Bone Marrow Transplant; 1991; 7 Suppl 2():91. PubMed ID: 1878739
    [No Abstract]   [Full Text] [Related]  

  • 8. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique.
    Rubie H; Plantaz D; Coze C; Michon J; Frappaz D; Baranzelli MC; Chastagner P; Peyroulet MC; Hartmann O;
    Med Pediatr Oncol; 2001 Jan; 36(1):247-50. PubMed ID: 11464897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapse.
    Hosoi H; Iehara T; Tsuchiya K; Misawa A; Miyaji M; Yagyu S; Koizumi M; Nishimura T; Tokiwa K; Iwai N; Yanagisawa A; Sugimoto T
    J Pediatr Surg; 2007 Oct; 42(10):E9-12. PubMed ID: 17923188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
    Fetscher S; Lübbert M; Kanz L; Behringer D; Finke J; Mertelsmann R; Lange W
    Bone Marrow Transplant; 1997 Mar; 19(5):527-8. PubMed ID: 9052926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relapsed stage I neuroblastoma successfully treated by allogeneic bone marrow transplantation in second remission: case report of a 7-year-old girl].
    Hanada R; Yaginuma A; Hayashi Y; Inaba T; Yamamoto K; Imaizumi S; Hirata A; Sugawara T; Aihara T; Miyakawa T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1937-9. PubMed ID: 2203317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
    Koga Y; Matsuzaki A; Suminoe A; Hatano M; Saito Y; Kinoshita Y; Tajiri T; Taguchi T; Kohashi K; Oda Y; Tsuneyoshi M; Hara T
    Pediatr Blood Cancer; 2009 Jul; 52(7):888-90. PubMed ID: 19260106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort.
    Wessalowski R; Blohm M; Calaminus G; Engert J; Harms D; Krause I; Kruck H; Grüttner HP; Pape H; Göbel U
    Klin Padiatr; 1997; 209(4):250-6. PubMed ID: 9293458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
    Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.